News about Biotechnology

Strategic Alliance Targets Faster, High-Yield Biologics Manufacturing

OneCyte and Kemp Proteins have announced a strategic partnership to deliver advanced cell line development solutions for biopharmaceutical companies globally.

Biotechnology | 06/04/2026 | By Darshana |  234

NIH Scientists Discover Safer, Highly Potent Opioid with Potential for Pain and Addiction Treatment

A newly discovered opioid compound by NIH researchers shows strong pain relief without typical addiction risks, marking a potential breakthrough in safer pain management therapies.

Biotechnology | 06/04/2026 | By News Bureau |  264

Emcure Slashes Price of Semaglutide-Based Weight Loss Drug Poviztra in India

Emcure reduces the price of its semaglutide-based drug Poviztra, aiming to make effective weight management treatment more accessible to patients across India.

Biotechnology | 04/04/2026 | By News Bureau |  254

Symeres Partners Ambagon Therapeutics to Advance Molecular Glue Research for Cancer Treatment

The collaboration will evaluate novel small-molecule “molecular glues” to target colorectal cancer and other hard-to-treat diseases, aiming to expand next-generation drug discovery approaches.

Biotechnology | 02/04/2026 | By News Bureau |  212

NJ Bio, Aji Bio-Pharma Partner to Expand Access to AJICAP Platform

The collaboration between NJ Bio and Bio Pharma aims to accelerate development of next-generation antibody–drug conjugates through advanced site-specific conjugation technology.

Biotechnology | 01/04/2026 | By News Bureau |  203

India Emerges as High-Velocity Biopharma Innovation Hub: Endiya Report

India’s biopharma sector gains momentum as policy support, innovation and cost advantages position the country as a global R&D hub.

Biotechnology | 31/03/2026 | By News Bureau |  246

Sobi Advances Tryngolza Expansion with EMA Validation for sHTG

Sobi has announced that the European Medicines Agency (EMA) has validated its application to expand the indication of Tryngolza (olezarsen) for the treatment of adults with severe hypertriglyceridemia (sHTG), defined by triglyceride levels ≥880 mg/dL (≥10 mmol/L).

Biotechnology | 31/03/2026 | By Darshana |  307

NMPA Nod for GSK's Exdensur Boosts Biologics Manufacturing Momentum

GSK plc has received approval from China’s National Medical Products Administration (NMPA) for Exdensur (depemokimab) as an add-on maintenance therapy for severe asthma with an eosinophilic phenotype in patients aged 12 years and above.

Biotechnology | 31/03/2026 | By Darshana |  158

Eisai and Nuvation Bio Secure EMA Validation for Taletrectinib in Lung Cancer

EU regulator begins review of next-generation targeted therapy for advanced ROS1-positive non-small cell lung cancer.

Biotechnology | 30/03/2026 | By News Bureau |  351

Medtronic Secures FDA Nod for Stealth AXiS, Advancing Integrated Surgical Technology Manufacturing

Medtronic, a global leader in healthcare technology, has received clearance from the US Food and Drug Administration (FDA) for its Stealth AXiS surgical system for use in cranial and ear, nose, and throat (ENT) procedures.

Biotechnology | 30/03/2026 | By Darshana |  135